University of Arkansas for Medical Science

Little Rock, Arkansas 72205

1 studies enrolling now · 16 studies all time

What they study most

Advanced Carcinoma, Asymptomatic Multiple Myeloma, Chronic Lymphocytic Leukemia, Cystic Fibrosis, Depression, Eosinophilic Colitis, Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Gastroenteritis, Graft Rejection, Health Services for the Aged, Multiple Myeloma

Studies at this site

• Residual Gastric Content and GLP-1 — Recruiting now
• Behavioral Pharmacology of Cannabis in Older Adults — Completed
• Characteristics of Eosinophilic Gastritis, Enteritis, and Colitis in a Multi-Site Cohort — Completed
• UARK 2014-14: Phase II Prospective Evaluation of Bone Remodeling During Ixazomib Treatment — Completed
• A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma — Stopped early
• UARK 2014-21 A Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus — Completed
• Efficacy and Safety Study of AeroVanc for the Treatment of Persistent MRSA Lung Infection in Cystic Fibrosis Patients — Completed
• UARK 2013-05 A Study of Autologous Expanded Natural Killer Cell Therapy for Asymptomatic Multiple Myeloma — Completed
• UARK 2015-03 A Phase II Trial of a Novel Proteasome/IMiD Combination — Withdrawn before enrolling
• A Study of Erlotinib (Tarceva) After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors — Completed
• Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL) — Completed
• A Study to Evaluate the Effect of Thymoglobulin and Reduced Doses of Steroids to Prevent Renal Transplant Rejection — Completed
• Study of Hyperbaric Oxygen Therapy in Addition to Standard Growth Factor Support for Hematopoietic Progenitor/Stem Cell Mobilization — Stopped early
• HORIZON-PFT: Pivotal Fracture Trial — Completed
• Telemedicine-Based Collaborative Care to Reduce Rural Disparities — Completed
• Double-blind Extension of HORIZON Pivotal Fracture Trial (Zoledronic Acid in the Treatment of Postmenopausal Osteoporosis) — Completed